| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | epidermis development | LGR4 LAMC1 LCE4A KRT31 KRT32 LCE1D KRT34 LCE2D LCE2C LCE3B SVEP1 LCE3A LCE2A LCE5A LCE2B | 1.34e-15 | 461 | 38 | 15 | GO:0008544 |
| GeneOntologyBiologicalProcess | keratinization | 4.07e-14 | 87 | 38 | 9 | GO:0031424 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | LAMC1 LCE4A KRT31 KRT32 LCE1D KRT34 KRT38 KRT37 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 1.32e-11 | 870 | 38 | 15 | GO:0030855 |
| GeneOntologyBiologicalProcess | skin development | LGR4 LAMC1 LCE4A LCE1D LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 4.54e-11 | 373 | 38 | 11 | GO:0043588 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 4.88e-11 | 189 | 38 | 9 | GO:0030216 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 7.04e-11 | 284 | 38 | 10 | GO:0009913 | |
| GeneOntologyBiologicalProcess | epithelium development | LGR4 LAMC1 LCE4A KRT31 KRT32 LCE1D KRT34 KRT38 KRT37 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 2.00e-09 | 1469 | 38 | 16 | GO:0060429 |
| GeneOntologyBiologicalProcess | intermediate filament organization | 2.54e-07 | 75 | 38 | 5 | GO:0045109 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.02e-06 | 99 | 38 | 5 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.07e-06 | 100 | 38 | 5 | GO:0045103 | |
| GeneOntologyCellularComponent | intermediate filament | KRTAP2-3 KRTAP2-1 KRTAP16-1 KRT31 KRT32 KRT34 KRTAP12-2 KRTAP2-4 KRT38 KRT37 KRTAP10-4 KRTAP12-4 | 2.00e-15 | 227 | 36 | 12 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP2-3 KRTAP2-1 KRTAP16-1 KRT31 KRT32 KRT34 KRTAP12-2 KRTAP2-4 KRT38 KRT37 KRTAP10-4 KRTAP12-4 | 1.17e-14 | 263 | 36 | 12 | GO:0045111 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRTAP2-3 KRTAP2-1 FHDC1 ODF1 KRTAP16-1 KRT31 KRT32 KRT34 KRTAP12-2 KRTAP2-4 KRT38 KRT37 KRTAP10-4 KRTAP12-4 | 1.05e-10 | 899 | 36 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | keratin filament | KRTAP2-3 KRTAP2-1 KRTAP16-1 KRTAP12-2 KRTAP2-4 KRTAP10-4 KRTAP12-4 | 2.78e-10 | 97 | 36 | 7 | GO:0045095 |
| GeneOntologyCellularComponent | supramolecular fiber | KRTAP2-3 KRTAP2-1 FHDC1 ODF1 KRTAP16-1 KRT31 KRT32 KRT34 KRTAP12-2 KRTAP2-4 KRT38 KRT37 KRTAP10-4 KRTAP12-4 | 3.60e-09 | 1179 | 36 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRTAP2-3 KRTAP2-1 FHDC1 ODF1 KRTAP16-1 KRT31 KRT32 KRT34 KRTAP12-2 KRTAP2-4 KRT38 KRT37 KRTAP10-4 KRTAP12-4 | 3.92e-09 | 1187 | 36 | 14 | GO:0099081 |
| Domain | SPRR/LCE | 7.63e-21 | 28 | 40 | 10 | IPR026075 | |
| Domain | LCE | 8.64e-21 | 17 | 40 | 9 | PF14672 | |
| Domain | LCE | 8.64e-21 | 17 | 40 | 9 | IPR028205 | |
| Domain | KAP | KRTAP2-3 KRTAP2-1 KRTAP16-1 KRTAP12-2 KRTAP2-4 KRTAP10-4 KRTAP12-4 | 3.30e-11 | 58 | 40 | 7 | IPR002494 |
| Domain | Keratin_B2 | 2.17e-08 | 40 | 40 | 5 | PF01500 | |
| Domain | Keratin_I | 3.55e-08 | 44 | 40 | 5 | IPR002957 | |
| Domain | Intermediate_filament_CS | 2.23e-07 | 63 | 40 | 5 | IPR018039 | |
| Domain | IF | 4.38e-07 | 72 | 40 | 5 | PS00226 | |
| Domain | Filament | 4.69e-07 | 73 | 40 | 5 | PF00038 | |
| Domain | IF | 5.75e-07 | 76 | 40 | 5 | IPR001664 | |
| Domain | TILa | 1.34e-05 | 3 | 40 | 2 | PF12714 | |
| Domain | TILa_dom | 1.34e-05 | 3 | 40 | 2 | IPR025615 | |
| Domain | Filament | 1.58e-05 | 71 | 40 | 4 | SM01391 | |
| Domain | EGF | 1.39e-04 | 235 | 40 | 5 | SM00181 | |
| Domain | EGF-like_dom | 1.82e-04 | 249 | 40 | 5 | IPR000742 | |
| Domain | - | 2.43e-04 | 11 | 40 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 2.43e-04 | 11 | 40 | 2 | IPR023413 | |
| Domain | TIL | 2.91e-04 | 12 | 40 | 2 | PF01826 | |
| Domain | C8 | 2.91e-04 | 12 | 40 | 2 | PF08742 | |
| Domain | Growth_fac_rcpt_ | 3.39e-04 | 156 | 40 | 4 | IPR009030 | |
| Domain | Unchr_dom_Cys-rich | 3.44e-04 | 13 | 40 | 2 | IPR014853 | |
| Domain | C8 | 3.44e-04 | 13 | 40 | 2 | SM00832 | |
| Domain | TIL_dom | 4.00e-04 | 14 | 40 | 2 | IPR002919 | |
| Domain | VWFD | 5.27e-04 | 16 | 40 | 2 | PS51233 | |
| Domain | VWD | 5.27e-04 | 16 | 40 | 2 | SM00216 | |
| Domain | VWF_type-D | 5.27e-04 | 16 | 40 | 2 | IPR001846 | |
| Domain | VWD | 5.27e-04 | 16 | 40 | 2 | PF00094 | |
| Domain | VWC_out | 7.47e-04 | 19 | 40 | 2 | SM00215 | |
| Domain | EGF_LAM_2 | 1.87e-03 | 30 | 40 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 1.87e-03 | 30 | 40 | 2 | PS01248 | |
| Domain | EGF_1 | 2.11e-03 | 255 | 40 | 4 | PS00022 | |
| Domain | EGF-like_CS | 2.29e-03 | 261 | 40 | 4 | IPR013032 | |
| Domain | EGF_2 | 2.42e-03 | 265 | 40 | 4 | PS01186 | |
| Domain | EGF | 2.47e-03 | 126 | 40 | 3 | PF00008 | |
| Domain | Laminin_EGF | 2.54e-03 | 35 | 40 | 2 | PF00053 | |
| Domain | EGF_Lam | 2.54e-03 | 35 | 40 | 2 | SM00180 | |
| Domain | VWC | 2.99e-03 | 38 | 40 | 2 | SM00214 | |
| Domain | Laminin_EGF | 2.99e-03 | 38 | 40 | 2 | IPR002049 | |
| Domain | Keratin_B2_2 | 3.15e-03 | 39 | 40 | 2 | PF13885 | |
| Domain | VWF_dom | 3.65e-03 | 42 | 40 | 2 | IPR001007 | |
| Domain | EGF_extracell | 7.32e-03 | 60 | 40 | 2 | IPR013111 | |
| Domain | EGF_2 | 7.32e-03 | 60 | 40 | 2 | PF07974 | |
| Domain | EGF_3 | 1.38e-02 | 235 | 40 | 3 | PS50026 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP2-3 KRTAP2-1 LELP1 LCE4A KRTAP16-1 KRT31 KRT32 LCE1D KRT34 KRTAP12-2 KRTAP2-4 KRT38 KRT37 LCE2D LCE2C LCE3B LCE3A KRTAP10-4 LCE2A KRTAP12-4 LCE5A LCE2B | 2.52e-33 | 217 | 32 | 22 | M27640 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | LELP1 LCE4A KRT31 KRT32 LCE1D KRT34 KRT38 KRT37 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 5.68e-23 | 129 | 32 | 15 | M27649 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP2-3 LAMC1 KRTAP2-1 LELP1 LCE4A KRTAP16-1 ZFP36L2 KRT31 KRT32 LCE1D KRT34 KRTAP12-2 KRTAP2-4 KRT38 KRT37 LCE2D LCE2C LCE3B LCE3A KRTAP10-4 LGI3 LCE2A KRTAP12-4 LCE5A LCE2B | 2.03e-19 | 1432 | 32 | 25 | M509 |
| Pathway | REACTOME_KERATINIZATION | KRTAP2-3 KRTAP2-1 KRTAP16-1 KRT31 KRT32 KRT34 KRTAP12-2 KRTAP2-4 KRTAP10-4 KRTAP12-4 | 8.86e-13 | 153 | 32 | 10 | MM15343 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP2-3 KRTAP2-1 KRTAP16-1 KRT31 KRT32 KRT34 KRTAP12-2 KRTAP2-4 KRTAP10-4 LGI3 KRTAP12-4 | 6.86e-09 | 502 | 32 | 11 | MM14537 |
| Pathway | WP_VITAMIN_D_RECEPTOR_PATHWAY | 3.21e-06 | 185 | 32 | 6 | M39718 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 9.89e-04 | 87 | 32 | 3 | MM15351 | |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | KRTAP2-3 CRCT1 LELP1 LCE4A KRT31 KRT32 LCE1D KRT34 KRTAP12-2 KRTAP2-4 KRT38 KRT37 LCE2D LCE2C LCE3B LCE3A KRTAP10-4 LCE2A KRTAP12-4 LCE5A LCE2B | 1.79e-26 | 630 | 40 | 21 | 36949045 |
| Pubmed | 6.57e-22 | 22 | 40 | 9 | 15854049 | ||
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 1.08e-21 | 23 | 40 | 9 | 11698679 | |
| Pubmed | 1.85e-20 | 16 | 40 | 8 | 17410201 | ||
| Pubmed | 1.95e-13 | 9 | 40 | 5 | 7686952 | ||
| Pubmed | The catalog of human hair keratins. I. Expression of the nine type I members in the hair follicle. | 3.90e-13 | 10 | 40 | 5 | 10391933 | |
| Pubmed | CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins. | 5.23e-11 | 7 | 40 | 4 | 36804407 | |
| Pubmed | Characterization of a 190-kilobase pair domain of human type I hair keratin genes. | 1.88e-10 | 9 | 40 | 4 | 9756910 | |
| Pubmed | The disruption of Sox21-mediated hair shaft cuticle differentiation causes cyclic alopecia in mice. | 8.85e-09 | 21 | 40 | 4 | 19470461 | |
| Pubmed | 1.04e-08 | 63 | 40 | 5 | 16831889 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | CRCT1 LELP1 LCE4A LCE1D GPR157 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A | 1.55e-08 | 1031 | 40 | 11 | 16710414 |
| Pubmed | Whn and mHa3 are components of the genetic hierarchy controlling hair follicle differentiation. | 2.81e-08 | 6 | 40 | 3 | 10559501 | |
| Pubmed | Protein-protein interaction panel using mouse full-length cDNAs. | 3.02e-08 | 161 | 40 | 6 | 11591653 | |
| Pubmed | 9.64e-08 | 37 | 40 | 4 | 11279113 | ||
| Pubmed | 6.35e-07 | 15 | 40 | 3 | 10087197 | ||
| Pubmed | 7.81e-07 | 16 | 40 | 3 | 15028290 | ||
| Pubmed | Psoriasis-Associated Late Cornified Envelope (LCE) Proteins Have Antibacterial Activity. | 3.87e-06 | 3 | 40 | 2 | 28634035 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 27048876 | ||
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 9878246 | ||
| Pubmed | Spatiotemporal expression pattern of keratins in skin of AP-2alpha-deficient mice. | 5.77e-05 | 10 | 40 | 2 | 10571739 | |
| Pubmed | 7.01e-05 | 69 | 40 | 3 | 18721477 | ||
| Pubmed | 7.05e-05 | 11 | 40 | 2 | 14962103 | ||
| Pubmed | SVEP1 is an endogenous ligand for the orphan receptor PEAR1. | 7.05e-05 | 11 | 40 | 2 | 36792666 | |
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 15617563 | ||
| Pubmed | Sequence and expression of murine type I hair keratins mHa2 and mHa3. | 1.16e-04 | 14 | 40 | 2 | 7514534 | |
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 1.61e-04 | 238 | 40 | 4 | 35864588 | |
| Pubmed | 2.19e-04 | 258 | 40 | 4 | 10830953 | ||
| Pubmed | 2.46e-04 | 266 | 40 | 4 | 19380743 | ||
| Pubmed | Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients. | 2.67e-04 | 21 | 40 | 2 | 19601998 | |
| Pubmed | 3.80e-04 | 25 | 40 | 2 | 10051316 | ||
| Pubmed | 7.07e-04 | 34 | 40 | 2 | 10613844 | ||
| Interaction | LCE1C interactions | KRTAP2-3 CRCT1 LCE4A ODF1 LCE1D KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP12-4 LCE5A LCE2B | 1.11e-27 | 77 | 37 | 15 | int:LCE1C |
| Interaction | LCE2A interactions | KRTAP2-3 CRCT1 LCE4A LCE1D KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP12-4 LCE5A LCE2B | 4.28e-26 | 69 | 37 | 14 | int:LCE2A |
| Interaction | KRTAP5-2 interactions | KRTAP2-3 CRCT1 LELP1 LCE4A LCE1D KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 1.94e-24 | 62 | 37 | 13 | int:KRTAP5-2 |
| Interaction | LCE2B interactions | KRTAP2-3 CRCT1 LCE4A LCE1D KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 8.57e-23 | 81 | 37 | 13 | int:LCE2B |
| Interaction | LCE1B interactions | KRTAP2-3 LCE4A KRT31 LCE1D KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3B LCE2A KRTAP12-4 LCE5A LCE2B | 1.68e-22 | 85 | 37 | 13 | int:LCE1B |
| Interaction | HOXA1 interactions | KRTAP2-3 LCE4A ODF1 KRT31 LCE1D KRT34 KRTAP12-2 KRTAP2-4 KRT38 KRT37 LCE2D LCE2C LCE3A KRTAP10-4 LCE2A KRTAP12-4 LCE5A LCE2B | 2.38e-22 | 356 | 37 | 18 | int:HOXA1 |
| Interaction | LCE2C interactions | KRTAP2-3 CRCT1 LCE4A LCE1D KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP12-4 LCE5A LCE2B | 2.72e-22 | 88 | 37 | 13 | int:LCE2C |
| Interaction | LCE1F interactions | KRTAP2-3 CRCT1 LCE4A LCE1D KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3B LCE2A KRTAP12-4 LCE5A LCE2B | 5.04e-22 | 92 | 37 | 13 | int:LCE1F |
| Interaction | KRTAP4-11 interactions | KRTAP2-3 CRCT1 LELP1 LCE4A LCE1D KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 5.04e-22 | 92 | 37 | 13 | int:KRTAP4-11 |
| Interaction | KRTAP9-8 interactions | KRTAP2-3 CRCT1 LCE4A LCE1D KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 1.59e-21 | 100 | 37 | 13 | int:KRTAP9-8 |
| Interaction | KRTAP9-3 interactions | KRTAP2-3 CRCT1 LCE4A KRT31 LCE1D KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 1.67e-21 | 140 | 37 | 14 | int:KRTAP9-3 |
| Interaction | KRTAP9-2 interactions | KRTAP2-3 CRCT1 LELP1 LCE4A KRT31 LCE1D KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 4.12e-21 | 149 | 37 | 14 | int:KRTAP9-2 |
| Interaction | LCE4A interactions | CRCT1 LCE4A KRT31 LCE1D KRTAP12-2 LCE2D LCE2C LCE3A LCE2A KRTAP12-4 LCE5A LCE2B | 1.11e-20 | 80 | 37 | 12 | int:LCE4A |
| Interaction | KRTAP4-12 interactions | KRTAP2-3 CRCT1 LELP1 LCE4A KRT31 LCE1D KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 1.26e-20 | 161 | 37 | 14 | int:KRTAP4-12 |
| Interaction | KRTAP4-4 interactions | KRTAP2-3 CRCT1 LCE4A LCE1D KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 1.30e-20 | 81 | 37 | 12 | int:KRTAP4-4 |
| Interaction | LCE1A interactions | KRTAP2-3 CRCT1 LCE4A KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3B LCE2A KRTAP12-4 LCE5A LCE2B | 2.06e-20 | 84 | 37 | 12 | int:LCE1A |
| Interaction | LCE5A interactions | KRTAP2-3 LCE4A LCE1D KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3B LCE2A KRTAP12-4 LCE5A LCE2B | 4.97e-20 | 90 | 37 | 12 | int:LCE5A |
| Interaction | KRTAP5-6 interactions | CRCT1 LELP1 LCE4A KRT31 LCE1D LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 8.62e-20 | 94 | 37 | 12 | int:KRTAP5-6 |
| Interaction | KRTAP5-4 interactions | CRCT1 LELP1 LCE4A LCE1D LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 8.90e-20 | 63 | 37 | 11 | int:KRTAP5-4 |
| Interaction | KRTAP5-11 interactions | KRTAP2-3 CRCT1 LELP1 LCE4A LCE1D KRTAP2-4 LCE2C LCE3B LCE3A LCE2A LCE5A | 1.55e-19 | 66 | 37 | 11 | int:KRTAP5-11 |
| Interaction | LCE1D interactions | KRTAP2-3 CRCT1 LCE4A LCE1D KRTAP2-4 LCE2D LCE2C LCE3B LCE2A LCE5A LCE2B | 3.10e-19 | 70 | 37 | 11 | int:LCE1D |
| Interaction | KRTAP5-9 interactions | KRTAP2-3 CRCT1 LELP1 LCE4A LCE1D KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 3.51e-19 | 203 | 37 | 14 | int:KRTAP5-9 |
| Interaction | KRTAP4-5 interactions | CRCT1 LELP1 LCE4A LCE1D LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 8.15e-19 | 76 | 37 | 11 | int:KRTAP4-5 |
| Interaction | LCE3A interactions | KRTAP2-3 CRCT1 LCE4A KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP12-4 LCE2B | 8.15e-19 | 76 | 37 | 11 | int:LCE3A |
| Interaction | KRTAP10-5 interactions | CRCT1 LELP1 LCE4A LCE1D KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 9.17e-19 | 160 | 37 | 13 | int:KRTAP10-5 |
| Interaction | KRTAP5-3 interactions | 2.26e-17 | 66 | 37 | 10 | int:KRTAP5-3 | |
| Interaction | TRIM42 interactions | KRTAP2-3 LCE4A LCE1D KRT34 KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3A LCE2A LCE5A LCE2B | 2.69e-17 | 149 | 37 | 12 | int:TRIM42 |
| Interaction | LCE1E interactions | KRTAP2-3 LCE4A LCE1D KRTAP2-4 LCE2D LCE2C LCE3B KRTAP12-4 LCE5A LCE2B | 3.11e-17 | 68 | 37 | 10 | int:LCE1E |
| Interaction | KRTAP10-1 interactions | KRTAP2-3 CRCT1 LCE4A LCE1D KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 3.72e-17 | 153 | 37 | 12 | int:KRTAP10-1 |
| Interaction | OTX1 interactions | KRTAP2-3 LCE4A KRT31 KRTAP12-2 KRTAP2-4 KRT37 LCE2D LCE2C KRTAP10-4 LCE2A KRTAP12-4 LCE2B | 4.37e-17 | 155 | 37 | 12 | int:OTX1 |
| Interaction | LCE2D interactions | KRTAP2-3 LCE4A LCE1D KRTAP2-4 LCE2D LCE2C LCE3A LCE2A LCE5A LCE2B | 7.62e-17 | 74 | 37 | 10 | int:LCE2D |
| Interaction | RGS17 interactions | 1.32e-16 | 48 | 37 | 9 | int:RGS17 | |
| Interaction | SMCP interactions | LCE4A KRT31 LCE1D KRT34 LCE2D LCE2C LCE3B LCE3A KRTAP12-4 LCE5A | 1.52e-16 | 79 | 37 | 10 | int:SMCP |
| Interaction | CYSRT1 interactions | KRTAP2-3 CRCT1 LCE4A KRT31 LCE1D KRT34 KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP12-4 LCE5A LCE2B | 1.82e-16 | 511 | 37 | 16 | int:CYSRT1 |
| Interaction | KRTAP12-4 interactions | KRTAP2-3 LCE4A KRTAP12-2 KRTAP2-4 LCE2C LCE3A LCE2A KRTAP12-4 LCE5A | 3.46e-16 | 53 | 37 | 9 | int:KRTAP12-4 |
| Interaction | KRTAP4-2 interactions | CRCT1 LCE4A LCE1D KRTAP12-2 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 4.61e-16 | 132 | 37 | 11 | int:KRTAP4-2 |
| Interaction | KRTAP2-3 interactions | KRTAP2-3 LCE1D KRTAP2-4 LCE2D LCE2C LCE3A LCE2A KRTAP12-4 LCE5A LCE2B | 1.04e-15 | 95 | 37 | 10 | int:KRTAP2-3 |
| Interaction | KRTAP2-4 interactions | KRTAP2-3 LCE1D KRTAP2-4 LCE2D LCE2C LCE3A LCE2A KRTAP12-4 LCE5A LCE2B | 1.97e-15 | 101 | 37 | 10 | int:KRTAP2-4 |
| Interaction | KRTAP10-11 interactions | 2.12e-15 | 64 | 37 | 9 | int:KRTAP10-11 | |
| Interaction | VASN interactions | KRTAP2-3 LCE4A KRT31 KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3A LCE2A LCE5A LCE2B | 3.99e-15 | 160 | 37 | 11 | int:VASN |
| Interaction | NBPF19 interactions | KRTAP2-3 LCE4A LCE1D KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3A LCE2A KRTAP12-4 LCE5A LCE2B | 6.16e-15 | 233 | 37 | 12 | int:NBPF19 |
| Interaction | KRTAP1-5 interactions | 2.05e-14 | 48 | 37 | 8 | int:KRTAP1-5 | |
| Interaction | NOTCH2NLA interactions | KRTAP2-3 CRCT1 LCE4A LCE1D KRTAP12-2 KRTAP2-4 LCE2D LCE2C LCE3A LCE2A KRTAP12-4 LCE5A LCE2B | 7.60e-14 | 381 | 37 | 13 | int:NOTCH2NLA |
| Interaction | KRTAP1-1 interactions | KRTAP2-3 LCE4A LCE1D KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 1.29e-13 | 219 | 37 | 11 | int:KRTAP1-1 |
| Interaction | SPRY1 interactions | 3.67e-13 | 111 | 37 | 9 | int:SPRY1 | |
| Interaction | KRTAP5-7 interactions | 5.62e-13 | 71 | 37 | 8 | int:KRTAP5-7 | |
| Interaction | RGS20 interactions | 6.43e-13 | 118 | 37 | 9 | int:RGS20 | |
| Interaction | LCE3D interactions | 7.09e-13 | 73 | 37 | 8 | int:LCE3D | |
| Interaction | KRTAP1-3 interactions | 8.86e-13 | 184 | 37 | 10 | int:KRTAP1-3 | |
| Interaction | LCE3B interactions | 1.96e-12 | 46 | 37 | 7 | int:LCE3B | |
| Interaction | KRTAP10-6 interactions | 3.32e-12 | 88 | 37 | 8 | int:KRTAP10-6 | |
| Interaction | KRTAP10-8 interactions | CRCT1 LELP1 LCE4A LCE1D KRTAP12-2 LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 3.87e-12 | 401 | 37 | 12 | int:KRTAP10-8 |
| Interaction | ZDHHC1 interactions | 4.32e-12 | 25 | 37 | 6 | int:ZDHHC1 | |
| Interaction | KRTAP12-3 interactions | 4.49e-12 | 146 | 37 | 9 | int:KRTAP12-3 | |
| Interaction | KRTAP10-9 interactions | 1.30e-11 | 241 | 37 | 10 | int:KRTAP10-9 | |
| Interaction | VWC2 interactions | 1.76e-11 | 62 | 37 | 7 | int:VWC2 | |
| Interaction | KRTAP4-1 interactions | 1.78e-11 | 31 | 37 | 6 | int:KRTAP4-1 | |
| Interaction | CRCT1 interactions | 2.77e-11 | 66 | 37 | 7 | int:CRCT1 | |
| Interaction | LCE3C interactions | 3.09e-11 | 67 | 37 | 7 | int:LCE3C | |
| Interaction | ALPP interactions | 5.09e-11 | 123 | 37 | 8 | int:ALPP | |
| Interaction | CATSPER1 interactions | KRTAP2-3 KRT31 LCE1D KRTAP12-2 KRTAP2-4 LCE2C KRTAP10-4 LCE5A | 6.18e-11 | 126 | 37 | 8 | int:CATSPER1 |
| Interaction | KRTAP12-2 interactions | 7.02e-11 | 128 | 37 | 8 | int:KRTAP12-2 | |
| Interaction | KRTAP10-7 interactions | 8.92e-11 | 293 | 37 | 10 | int:KRTAP10-7 | |
| Interaction | NUFIP2 interactions | KRTAP2-3 LCE4A KRT31 LCE1D KRTAP2-4 KRT37 LCE2D LCE2C LCE5A STAB1 LCE2B | 1.38e-10 | 417 | 37 | 11 | int:NUFIP2 |
| Interaction | CREB5 interactions | 5.12e-10 | 164 | 37 | 8 | int:CREB5 | |
| Interaction | KRTAP12-1 interactions | 1.58e-09 | 63 | 37 | 6 | int:KRTAP12-1 | |
| Interaction | CYP21A2 interactions | 3.60e-09 | 33 | 37 | 5 | int:CYP21A2 | |
| Interaction | CHIC2 interactions | 3.90e-09 | 73 | 37 | 6 | int:CHIC2 | |
| Interaction | KRT86 interactions | 4.60e-09 | 75 | 37 | 6 | int:KRT86 | |
| Interaction | ADAMTSL4 interactions | 4.69e-09 | 217 | 37 | 8 | int:ADAMTSL4 | |
| Interaction | POU4F2 interactions | 8.53e-09 | 83 | 37 | 6 | int:POU4F2 | |
| Interaction | KRTAP17-1 interactions | 2.55e-08 | 48 | 37 | 5 | int:KRTAP17-1 | |
| Interaction | HAPLN2 interactions | 2.83e-08 | 49 | 37 | 5 | int:HAPLN2 | |
| Interaction | GRN interactions | 3.52e-08 | 281 | 37 | 8 | int:GRN | |
| Interaction | BEX2 interactions | 3.74e-08 | 106 | 37 | 6 | int:BEX2 | |
| Interaction | JOSD1 interactions | 5.62e-08 | 56 | 37 | 5 | int:JOSD1 | |
| Interaction | KRT72 interactions | 7.34e-08 | 59 | 37 | 5 | int:KRT72 | |
| Interaction | KRT79 interactions | 7.34e-08 | 59 | 37 | 5 | int:KRT79 | |
| Interaction | SPRED2 interactions | 1.02e-07 | 63 | 37 | 5 | int:SPRED2 | |
| Interaction | KRTAP5-8 interactions | 3.17e-07 | 8 | 37 | 3 | int:KRTAP5-8 | |
| Interaction | KRTAP6-3 interactions | 4.48e-07 | 161 | 37 | 6 | int:KRTAP6-3 | |
| Interaction | KRT78 interactions | 5.22e-07 | 87 | 37 | 5 | int:KRT78 | |
| Interaction | DMRT3 interactions | 5.22e-07 | 87 | 37 | 5 | int:DMRT3 | |
| Interaction | KRT3 interactions | 5.53e-07 | 88 | 37 | 5 | int:KRT3 | |
| Interaction | KRT74 interactions | 6.08e-07 | 37 | 37 | 4 | int:KRT74 | |
| Interaction | KRT75 interactions | 8.91e-07 | 181 | 37 | 6 | int:KRT75 | |
| Interaction | TXLNG interactions | 9.45e-07 | 98 | 37 | 5 | int:TXLNG | |
| Interaction | KLHL38 interactions | 9.94e-07 | 99 | 37 | 5 | int:KLHL38 | |
| Interaction | SLC39A7 interactions | 1.08e-06 | 187 | 37 | 6 | int:SLC39A7 | |
| Interaction | KRT71 interactions | 1.13e-06 | 43 | 37 | 4 | int:KRT71 | |
| Interaction | KRT5 interactions | 1.30e-06 | 193 | 37 | 6 | int:KRT5 | |
| Interaction | TGFB1 interactions | 1.53e-06 | 317 | 37 | 7 | int:TGFB1 | |
| Interaction | PLA2G10 interactions | 1.92e-06 | 113 | 37 | 5 | int:PLA2G10 | |
| Interaction | TSPAN4 interactions | 2.64e-06 | 53 | 37 | 4 | int:TSPAN4 | |
| Interaction | KRT81 interactions | 2.64e-06 | 53 | 37 | 4 | int:KRT81 | |
| Interaction | KRT2 interactions | 4.15e-06 | 236 | 37 | 6 | int:KRT2 | |
| Interaction | LCE3E interactions | 4.36e-06 | 60 | 37 | 4 | int:LCE3E | |
| Interaction | ZNF587 interactions | 4.59e-06 | 135 | 37 | 5 | int:ZNF587 | |
| Interaction | KRT85 interactions | 4.66e-06 | 61 | 37 | 4 | int:KRT85 | |
| Interaction | KRT4 interactions | 4.97e-06 | 62 | 37 | 4 | int:KRT4 | |
| Cytoband | 1q21.3 | 8.48e-16 | 117 | 40 | 9 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | CRCT1 LELP1 LCE4A LCE1D LCE2D LCE2C LCE3B LCE3A LCE2A LCE5A LCE2B | 3.94e-14 | 404 | 40 | 11 | chr1q21 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | KRTAP2-3 KRTAP2-1 KRTAP16-1 KRT31 KRT32 KRT34 KRTAP2-4 KRT38 KRT37 | 2.50e-10 | 473 | 40 | 9 | chr17q21 |
| Cytoband | 17q21.2 | 4.50e-09 | 70 | 40 | 5 | 17q21.2 | |
| Cytoband | 17q12-q21 | 1.74e-08 | 32 | 40 | 4 | 17q12-q21 | |
| Cytoband | 21q22.3 | 1.94e-04 | 128 | 40 | 3 | 21q22.3 | |
| Cytoband | 1q21 | 2.89e-03 | 91 | 40 | 2 | 1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 4.33e-03 | 377 | 40 | 3 | chr21q22 | |
| GeneFamily | Late cornified envelope proteins | 3.27e-21 | 18 | 33 | 9 | 627 | |
| GeneFamily | Keratin associated proteins | KRTAP2-3 KRTAP2-1 KRTAP16-1 KRTAP12-2 KRTAP2-4 KRTAP10-4 KRTAP12-4 | 8.94e-10 | 109 | 33 | 7 | 619 |
| GeneFamily | Keratins, type I | 1.41e-09 | 28 | 33 | 5 | 608 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 9.68e-11 | 49 | 39 | 6 | MM452 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | FHDC1 KRT31 KRT32 LCE1D KRT34 KRTAP12-2 LCE2D LCE2C BICC1 KRTAP12-4 LCE5A | 1.29e-09 | 630 | 39 | 11 | MM1038 |
| Coexpression | CAMPS_COLON_CANCER_COPY_NUMBER_UP | 2.64e-07 | 93 | 39 | 5 | M18750 | |
| Coexpression | TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA | 4.19e-07 | 102 | 39 | 5 | M14455 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 5.44e-07 | 204 | 39 | 6 | MM966 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 4.31e-05 | 650 | 39 | 7 | MM1042 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 4.70e-05 | 659 | 39 | 7 | MM1040 | |
| CoexpressionAtlas | skin | CRCT1 LCE4A KRT31 KRT32 LCE1D KRT37 LCE2D LCE2C LGI3 LCE2A LCE5A LCE2B | 4.45e-12 | 456 | 35 | 12 | skin |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP2-3 KRTAP2-1 KRTAP16-1 KRT31 KRT32 KRTAP12-2 KRT38 KRTAP10-4 KRTAP12-4 | 7.80e-15 | 146 | 40 | 9 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor-3|TCGA-Testes / Sample_Type by Project: Shred V9 | 1.45e-09 | 125 | 40 | 6 | 5f90de494b53ecce6455034f3ed5dccdbb2c29ca | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.07e-08 | 106 | 40 | 5 | 117b53d525be929652fb998e250d7946170fbaf0 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.44e-07 | 190 | 40 | 5 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.44e-07 | 190 | 40 | 5 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.44e-07 | 190 | 40 | 5 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.24e-07 | 194 | 40 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 8.45e-07 | 195 | 40 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.18e-05 | 157 | 40 | 4 | 2553ebf3e48de5bd184e77bd61114faa5a1d95ed | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.25e-05 | 185 | 40 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.35e-05 | 187 | 40 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.55e-05 | 191 | 40 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.60e-05 | 192 | 40 | 4 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-05 | 192 | 40 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.66e-05 | 193 | 40 | 4 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 2.71e-05 | 194 | 40 | 4 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.71e-05 | 194 | 40 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.71e-05 | 194 | 40 | 4 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 2.71e-05 | 194 | 40 | 4 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.77e-05 | 195 | 40 | 4 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 2.77e-05 | 195 | 40 | 4 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.77e-05 | 195 | 40 | 4 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Diffuse_Sclerosing-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.04e-05 | 74 | 40 | 3 | d7a7a946ef5a28bccd45e0ba4bc7a12e54f0cc64 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Recurrent_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 7.74e-05 | 92 | 40 | 3 | b728c0faf742c9235b891e3acf34d18a0e335c22 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Recurrent_Tumor-Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 7.74e-05 | 92 | 40 | 3 | 207cde9de6f37b33e47bc6f9c32c9877ab7cbe63 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-04 | 125 | 40 | 3 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | mild_COVID-19-B_cell|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.25e-04 | 132 | 40 | 3 | 4b372483bc106aecc7b96a09131e1695e54e7dc4 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-04 | 133 | 40 | 3 | f7d0763b5eec2db33044d6850fd57462494038c1 | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 2.41e-04 | 135 | 40 | 3 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | Dendritic_Cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.54e-04 | 154 | 40 | 3 | 65013f696da623d37f1e3447a294dfb3c31ae93b | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.82e-04 | 158 | 40 | 3 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 4.64e-04 | 169 | 40 | 3 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-6|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 4.72e-04 | 170 | 40 | 3 | 3dba3f810fbd1eadf446b52e4c9c971d362a80e1 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 4.81e-04 | 171 | 40 | 3 | fcc31a9a69f96de10d1324a5a4fbfe4289bf4984 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.89e-04 | 172 | 40 | 3 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.97e-04 | 173 | 40 | 3 | 1b2508cc890430bd4b2cf232c633928edb86c57e | |
| ToppCell | facs-Skin-nan-18m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-04 | 176 | 40 | 3 | 086197acbfec4ac0c15b7e9721871aaa9e32e219 | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 5.23e-04 | 176 | 40 | 3 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-9|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.31e-04 | 177 | 40 | 3 | ae55773c531099a9e94f44f01ba48b5e71dddc53 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.49e-04 | 179 | 40 | 3 | 3d3716078afdb9a89ddfadb3197cd1b52fa770be | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 5.49e-04 | 179 | 40 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-04 | 180 | 40 | 3 | 18bf8561ad3aa9787d2a8ef942a96f641734c608 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-04 | 180 | 40 | 3 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-04 | 180 | 40 | 3 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.58e-04 | 180 | 40 | 3 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.67e-04 | 181 | 40 | 3 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.67e-04 | 181 | 40 | 3 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | droplet-Lung-nan-21m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-04 | 182 | 40 | 3 | 40539ade8c3cd12b61f1cd0d493828e58282796b | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.76e-04 | 182 | 40 | 3 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.14e-04 | 186 | 40 | 3 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.14e-04 | 186 | 40 | 3 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|World / Lineage and Cell class | 6.14e-04 | 186 | 40 | 3 | 6ca8ce7ced91d6308b7c056032ffec1b37c974bf | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-04 | 187 | 40 | 3 | 1669df899b1759c338ffce196fe009840123cfcd | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.23e-04 | 187 | 40 | 3 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.23e-04 | 187 | 40 | 3 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 6.23e-04 | 187 | 40 | 3 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-04 | 187 | 40 | 3 | f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.23e-04 | 187 | 40 | 3 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.33e-04 | 188 | 40 | 3 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 6.33e-04 | 188 | 40 | 3 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-04 | 189 | 40 | 3 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-04 | 189 | 40 | 3 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-04 | 189 | 40 | 3 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-04 | 189 | 40 | 3 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.53e-04 | 190 | 40 | 3 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.53e-04 | 190 | 40 | 3 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.53e-04 | 190 | 40 | 3 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 190 | 40 | 3 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.53e-04 | 190 | 40 | 3 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.53e-04 | 190 | 40 | 3 | e950f40d578c1eec8c6030cf1cb51823eac24bc7 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 190 | 40 | 3 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.53e-04 | 190 | 40 | 3 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.53e-04 | 190 | 40 | 3 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.53e-04 | 190 | 40 | 3 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.63e-04 | 191 | 40 | 3 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Dendritic_Cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.63e-04 | 191 | 40 | 3 | b51c8ff1279581088557bb36760c70209c77148c | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.63e-04 | 191 | 40 | 3 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 191 | 40 | 3 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 191 | 40 | 3 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 191 | 40 | 3 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.63e-04 | 191 | 40 | 3 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.63e-04 | 191 | 40 | 3 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.63e-04 | 191 | 40 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.73e-04 | 192 | 40 | 3 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.73e-04 | 192 | 40 | 3 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.73e-04 | 192 | 40 | 3 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.73e-04 | 192 | 40 | 3 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.73e-04 | 192 | 40 | 3 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.73e-04 | 192 | 40 | 3 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 192 | 40 | 3 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.73e-04 | 192 | 40 | 3 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.73e-04 | 192 | 40 | 3 | 321850b0f881420c2d57d3e825e365c82fa511ab | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.73e-04 | 192 | 40 | 3 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 192 | 40 | 3 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.73e-04 | 192 | 40 | 3 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 192 | 40 | 3 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.73e-04 | 192 | 40 | 3 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.73e-04 | 192 | 40 | 3 | cf2765d8bc074f7f9ee864eae632a3b705175842 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.73e-04 | 192 | 40 | 3 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.73e-04 | 192 | 40 | 3 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| Computational | Placenta genes. | 3.04e-04 | 463 | 15 | 5 | MODULE_38 | |
| Computational | Neighborhood of RING1 | 4.57e-04 | 112 | 15 | 3 | GCM_RING1 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | 5.86e-04 | 835 | 15 | 6 | MODULE_88 | |
| Computational | Neighborhood of HMGA2 | 6.02e-04 | 123 | 15 | 3 | GCM_HMGA2 | |
| Computational | Neighborhood of LTK | 1.82e-03 | 46 | 15 | 2 | GCM_LTK | |
| Computational | Trachea genes. | 2.13e-03 | 415 | 15 | 4 | MODULE_6 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.14e-03 | 50 | 15 | 2 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_3 | |
| Computational | Neighborhood of PRKAG1 | 2.14e-03 | 50 | 15 | 2 | GCM_PRKAG1 | |
| Computational | Genes in the cancer module 379. | 2.59e-03 | 204 | 15 | 3 | MODULE_379 | |
| Computational | Genes in the cancer module 242. | 2.97e-03 | 214 | 15 | 3 | MODULE_242 | |
| Computational | Neighborhood of PRKCG | 3.38e-03 | 63 | 15 | 2 | GCM_PRKCG | |
| Computational | Genes in the cancer module 55. | 4.28e-03 | 832 | 15 | 5 | MODULE_55 | |
| Drug | AC1L1I0J | 1.29e-10 | 19 | 39 | 5 | CID000004371 | |
| Drug | Vistar | 4.10e-09 | 36 | 39 | 5 | CID000040896 | |
| Drug | Norakin | 4.65e-09 | 3 | 39 | 3 | CID000161077 | |
| Drug | 9-(5',5'-difluoro-5'-phosphonopentyl)guanine | 1.47e-08 | 46 | 39 | 5 | CID000448999 | |
| Drug | NSC34533 | 3.36e-08 | 54 | 39 | 5 | CID000003512 | |
| Drug | CK17 | 4.43e-08 | 57 | 39 | 5 | CID000128831 | |
| Drug | DOPAC | 1.33e-06 | 112 | 39 | 5 | CID000000547 | |
| Drug | teleocidin B | 2.11e-06 | 123 | 39 | 5 | CID000072425 | |
| Drug | sulfur mustard | 2.77e-06 | 130 | 39 | 5 | CID000010461 | |
| Drug | homocysteine thiolactone | 2.87e-06 | 131 | 39 | 5 | CID000107712 | |
| Drug | al-Badry | 8.87e-06 | 165 | 39 | 5 | CID000004545 | |
| Drug | desethylaprindine | 1.71e-05 | 4 | 39 | 2 | CID000162697 | |
| Drug | AC1L9MJT | 1.85e-05 | 192 | 39 | 5 | CID000448959 | |
| Drug | tartryl diazide | 2.85e-05 | 5 | 39 | 2 | CID000193925 | |
| Drug | podocarpic acid | 4.27e-05 | 6 | 39 | 2 | CID000093017 | |
| Drug | 5-dehydrosparteine | 4.27e-05 | 6 | 39 | 2 | CID000160614 | |
| Drug | N-NBD-PE | 1.02e-04 | 9 | 39 | 2 | CID000127398 | |
| Drug | 1-2q | 1.29e-04 | 289 | 39 | 5 | CID000011820 | |
| Drug | HA22 | 1.87e-04 | 12 | 39 | 2 | CID003035755 | |
| Disease | psoriasis, COVID-19 | 1.21e-06 | 2 | 33 | 2 | EFO_0000676, MONDO_0100096 | |
| Disease | atopic eczema | 1.75e-04 | 252 | 33 | 4 | EFO_0000274 | |
| Disease | hair shape measurement | 4.18e-04 | 27 | 33 | 2 | EFO_0007824 | |
| Disease | hair morphology | 4.83e-04 | 29 | 33 | 2 | EFO_0005038 | |
| Disease | psoriasis vulgaris | 2.13e-03 | 61 | 33 | 2 | EFO_1001494 | |
| Disease | psoriasis, type 2 diabetes mellitus | 3.20e-03 | 75 | 33 | 2 | EFO_0000676, MONDO_0005148 | |
| Disease | psoriasis | 3.48e-03 | 273 | 33 | 3 | EFO_0000676 | |
| Disease | Hodgkins lymphoma | 3.81e-03 | 82 | 33 | 2 | EFO_0000183 | |
| Disease | vitamin D measurement | 6.20e-03 | 336 | 33 | 3 | EFO_0004631 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APAPTPAPASSSSCC | 26 | Q9UGL9 | |
| CPSLGCPSVVPSPCS | 201 | P78524 | |
| ATSPPMSPCSCPQCV | 181 | Q9Y2E6 | |
| TSPSPASCPAGLACP | 426 | Q9H694 | |
| PCSCSREECPSSPPP | 46 | Q9C0D6 | |
| CPSQSPSSCPPQPCT | 61 | Q5T871 | |
| LSNPCTSCVPPAPCT | 386 | Q15323 | |
| PCNPCSTPASCTSCP | 416 | O76014 | |
| STPASCTSCPSCGPV | 421 | O76014 | |
| PCSTPSCTTCVPSPC | 411 | Q14532 | |
| PCNPCSTSPSCVTAP | 416 | O76015 | |
| CAPRPSCGPCTTCGP | 431 | O76015 | |
| PPCGQPTPCSTTCRT | 111 | P0C7H8 | |
| FFGPVSCPCCGTSPT | 451 | Q5VWM3 | |
| TEPLPSQCCGSGCSP | 21 | Q6IPT4 | |
| PPCGQPTPCSTTCRT | 111 | Q9BYU5 | |
| PSGAAPPLCAAPCSC | 21 | Q9BXB1 | |
| PPCGQPTPCSTTCRT | 111 | Q9BYR9 | |
| TSPCSPCSPCSPCNP | 206 | Q14990 | |
| SPCNPCSPCNPCSPY | 216 | Q14990 | |
| YEVCGSPCPASCPSP | 1956 | Q9Y6R7 | |
| SCPVSCPSLSAPEGC | 4751 | Q9Y6R7 | |
| CCCSSQPPTKSPAGT | 296 | Q5UAW9 | |
| PVPSCCAPTSSCQPS | 376 | P60372 | |
| PKCPPVSSCCSVSSG | 31 | Q5T752 | |
| CPPPVSSCCGPSSGG | 36 | Q5TA79 | |
| CPAPCSPAVSSCCGP | 36 | O14633 | |
| CPAPCFPAVSSCCGP | 36 | Q5TA81 | |
| CPAPCSPAVSSCCGP | 36 | Q5TA82 | |
| PAQCLPPASSSCAPS | 21 | Q5TA76 | |
| APSPCQPACCVPSSC | 16 | P59991 | |
| PPASSCCAPRPGCCG | 31 | Q5TA77 | |
| PMACPGSPCCVPSTC | 11 | P60329 | |
| PSKCASSCPPPISSC | 26 | Q5TA78 | |
| SSCPPPISSCCGSSS | 31 | Q5TA78 | |
| SAPCPPPVSSCCGSS | 41 | Q5TCM9 | |
| TSSDCQPCPCPGGSS | 766 | P11047 | |
| PSPCSPAVCVSSPCQ | 316 | A8MUX0 | |
| TSCSSRPCVPPSCHG | 56 | O76011 | |
| SGSSPSCLPCRCSTP | 2996 | Q4LDE5 | |
| SECQACPGGPSSPCS | 1966 | Q9NY15 | |
| RTPPPPSCSSASSCS | 286 | P47974 | |
| ACPCPASSGSSSCTP | 306 | Q9H0D2 | |
| RCPPGSSYSPCSSPC | 1811 | Q9Y493 | |
| TPPCPPSCSCTRDTA | 36 | Q8N145 |